Watch the recording of a webinar with Dr. Dave Rabin and Dr. James Leathem: The Importance of Mitigating Patient Anxiety When Administering Psychedelic Medicine.
Over the last year, several ketamine clinics have reached out to share how they have successfully and independently integrated Apollo into their clinical practices as a means to outfit their clinicians and clients with better non-invasive tools to support the healing process.
As an initial step, we co-developed a curriculum and set of materials with some of these clinicians that integrated the Apollo wearable before, during, and after Ketamine sessions. We are incredibly encouraged by the results and are excited to create more data on the emerging role of wearables and expand the opportunity to 20 more clinics.
Want to learn more? Our team would love to learn more about how you want to work with Apollo. Fill out this quick form to get started and our team will be in touch.
Ready to bring Apollo to your clinic? We’re offering certified refurbished Apollo wearables in bulk orders (over 5 devices) at over 40% off. We’d love to help bring Apollo to your office, whether it's for your clients, implementing into your practice or providing to your staff.
Learn more
Apollo Neuro is a wearable device that works by sending low-frequency sound wave vibrations to touch receptors in the skin, which gently stimulate the vagus nerve. When the vagus nerve is activated in this manner, it calms the body and mind, reducing stress and promoting relaxation. Apollo is the first wearable technology used by clinicians to accompany psychedelic medicine experiences to improve client comfort, reduce anxiety, and improve treatment responses, regardless of whether psychotherapy is part of the treatment experience.
The Apollo wearable is the first technology patented to reduce unpleasant/unwanted side effects that arise from ketamine treatment.
About the speakers
Dr. Deepak Sharma, MD, MBA is a Board Certified Anesthesiologist and a member of the American Society of Anesthesiologists. He completed three degrees at Drexel University in Philadelphia, PA: a Bachelor in Finance, a Master in Business Administration, and a Doctor of Medicine. He went on to complete residency at the Mount Sinai Morningside-West Hospital System in New York, NY and post-graduate fellowship at Stanford Medical Center in Palo Alto, CA.
Dr. David Rabin, MD, PhD, a board-certified psychiatrist and neuroscientist, is the co-founder & chief innovation officer at Apollo Neuro, the first scientifically-validated wearable system to improve heart rate variability, focus, relaxation, and sleep by delivering gentle layered vibrations to the skin. In addition to his clinical psychiatry practice, Dr. Rabin is also the co-founder & executive director of The Board of Medicine, and a psychedelic clinical researcher currently evaluating the mechanism of psychedelic-assisted psychotherapy in treatment-resistant mental illnesses.